Skip to main content
All lobbying filings

ACCENDRA HEALTH INC.

Lobbying for ACCENDRA HEALTH INC.

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 19, 2026
Expenses
$240,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Virginia

Official filing document

 Government bodies contacted 6
  • Centers For Medicare and Medicaid Services (CMS)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • Office of Management & Budget (OMB)
  • Office of the Vice President of the United States
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 4
 Lobbying activity 5
Health Issues

Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.

Medicare/Medicaid

Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.

Trade (domestic/foreign)

Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.

Budget/Appropriations

FY 2026 Appropriations.

Veterans

CHAMPVA medical supply reimbursement.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem